Back to funds

Saturn V Capital Management LP

Updated 6 days ago

Managed by Saturn V Capital Management Lp • Latest filing Q3 2026

Portfolio value
$683.1M
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$544.9M
Q1 2026$552.2M
Q2 2026$697.5M
Q3 2026$683.1M

Top holdings

24 positions as of Q3 2026

View filing
A

AMYLYX PHARMACEUTICALS INC

Value
$130.1M
Shares
4.47M
% Port
19.05%
A

ABIVAX SA

Value
$52.4M
Shares
529.3K
% Port
7.67%
?
3.N/A

IMMIX BIOPHARMA INC

Value
$48.5M
Shares
4.66M
% Port
7.10%
P

PHARVARIS N V

Value
$44.2M
Shares
1.39M
% Port
6.47%
P

VAXCYTE INC

Value
$43.9M
Shares
772.3K
% Port
6.43%
C

CELCUITY INC

Value
$40.9M
Shares
513.8K
% Port
5.98%
I

DISC MEDICINE INC

Value
$40.1M
Shares
612.7K
% Port
5.87%
C

CANDEL THERAPEUTICS INC

Value
$36.3M
Shares
3.48M
% Port
5.31%
J

JAZZ PHARMACEUTICALS PLC

Value
$34.8M
Shares
150.3K
% Port
5.10%
M

MONOPAR THERAPEUTICS INC

Value
$24.9M
Shares
312.4K
% Port
3.64%
V

VIR BIOTECHNOLOGY INC

Value
$22.8M
Shares
2.04M
% Port
3.34%
T

TREVI THERAPEUTICS INC

Value
$22.5M
Shares
1.57M
% Port
3.30%
?
13.N/A

X4 PHARMACEUTICALS INC

Value
$21.4M
Shares
7.37M
% Port
3.13%
A

ALUMIS INC

Value
$21.1M
Shares
2.86M
% Port
3.09%
S

SAGIMET BIOSCIENCES INC

Value
$19.8M
Shares
2.00M
% Port
2.90%
D

DYNE THERAPEUTICS INC

Value
$13.5M
Shares
837.2K
% Port
1.97%
A

ALTO NEUROSCIENCE INC

Value
$13.2M
Shares
518.1K
% Port
1.94%
R

ULTRAGENYX PHARMACEUTICAL IN

Value
$11.4M
Shares
758.8K
% Port
1.67%
Z

ZURA BIO LTD

Value
$8.5M
Shares
2.03M
% Port
1.24%
I

INHIBIKASE THERAPEUTICS INC

Value
$8M
Shares
3.87M
% Port
1.16%

Explore